{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:42:46Z","timestamp":1790808166989,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,24]],"date-time":"2016-04-24T00:00:00Z","timestamp":1461456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["297\/09\/F14"],"award-info":[{"award-number":["297\/09\/F14"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["9962"],"award-info":[{"award-number":["9962"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaut.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T03:15:04Z","timestamp":1462331704000},"page":"8-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5599-9788","authenticated-orcid":false,"given":"Alice","family":"Laroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Armentani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kerlero de Rosbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ivaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marcenaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sivori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopali","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni L.","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nri3349","article-title":"Innate lymphoid cells\u2013how did we miss them?","volume":"13","author":"Walker","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.04.003_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.04.003_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.04.003_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","article-title":"Receptors for HLA class-I molecules in human natural killer cells","volume":"14","author":"Moretta","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.04.003_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2016.04.003_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2016.04.003_bib7","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jaut.2016.04.003_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/imt.11.99","article-title":"NK cells and their receptors during viral infections","volume":"3","author":"Marcenaro","year":"2011","journal-title":"Immunotherapy"},{"issue":"10","key":"10.1016\/j.jaut.2016.04.003_bib9","doi-asserted-by":"crossref","first-page":"e26173","DOI":"10.1371\/journal.pone.0026173","article-title":"IL-27 imparts immunoregulatory function to human NK cell subsets","volume":"6","author":"Laroni","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaut.2016.04.003_bib10","first-page":"965","article-title":"CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950"},{"issue":"4","key":"10.1016\/j.jaut.2016.04.003_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"issue":"3","key":"10.1016\/j.jaut.2016.04.003_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","article-title":"Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta","volume":"28","author":"Saraste","year":"2007","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2007.03555.x","article-title":"Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells","volume":"151","author":"Airas","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"15","key":"10.1016\/j.jaut.2016.04.003_bib14","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","article-title":"An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells","volume":"185","author":"Martin","year":"2010","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"10","key":"10.1016\/j.jaut.2016.04.003_bib17","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jaut.2016.04.003_bib18","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2016.04.003_bib19","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.1100885","article-title":"B\u00a0cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients","volume":"187","author":"Schneider","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.04.003_bib20","first-page":"41","article-title":"Cell isolation and expansion using Dynabeads","volume":"106","author":"Neurauter","year":"2007","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"7","key":"10.1016\/j.jaut.2016.04.003_bib21","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.072065999","article-title":"Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in\u00a0vitro differentiation","volume":"99","author":"Sivori","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jaut.2016.04.003_bib22","doi-asserted-by":"crossref","first-page":"e1001224","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.jaut.2016.04.003_bib23","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.145.10.3194","article-title":"Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis","volume":"145","author":"Robertson","year":"1990","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"6669","key":"10.1016\/j.jaut.2016.04.003_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib25","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1212\/NXI.0000000000000065","article-title":"CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS","volume":"2","author":"Elkins","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib26","doi-asserted-by":"crossref","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2016.04.003_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaut.2016.04.003_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.04.003_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00105","article-title":"TLR\/NCR\/KIR: which ones to use and when?","volume":"5","author":"Sivori","year":"2014","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2016.04.003_bib30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2016.04.003_bib31","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"6","key":"10.1016\/j.jaut.2016.04.003_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jaut.2016.04.003_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imm.12012","article-title":"Increased HLA-E expression in white matter lesions in multiple sclerosis","volume":"137","author":"Durrenberger","year":"2012","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.jaut.2016.04.003_bib34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s11481-013-9459-3","article-title":"Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation","volume":"8","author":"Morandi","year":"2013","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2016.04.003_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","article-title":"Role of the innate immune system in the pathogenesis of multiple sclerosis","volume":"221","author":"Gandhi","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jaut.2016.04.003_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","article-title":"Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway","volume":"26","author":"Lu","year":"2007","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jaut.2016.04.003_bib37","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.0914732107","article-title":"Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2","volume":"107","author":"Leavenworth","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jaut.2016.04.003_bib38","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.4049\/jimmunol.170.7.3572","article-title":"Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells","volume":"170","author":"Rabinovich","year":"2003","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"170","key":"10.1016\/j.jaut.2016.04.003_bib39","doi-asserted-by":"crossref","first-page":"170ra115","DOI":"10.1126\/scitranslmed.3004970","article-title":"In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling","volume":"5","author":"Schneider","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.jaut.2016.04.003_bib40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/WNL.0000000000000222","article-title":"Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis","volume":"82","author":"Oh","year":"2014","journal-title":"Neurology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684111630035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684111630035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:14:47Z","timestamp":1760256887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684111630035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"alternative-id":["S089684111630035X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.04.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}